Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-02-26 Sale | 2025-02-28 4:48 pm | Cyclacel Pharmaceuticals Inc. | CYCC | Lazar David E. Interim CEO 10% Owner | 194,628,820 | $0.0283 | $5,507,996 | 354,738 (Direct) | View |
| 2023-12-21 Purchase | 2023-12-26 4:05 pm | Cyclacel Pharmaceuticals Inc. | CYCC | McBarron Paul See Remarks | 1,886 | $3.315 | $6,252 | 35,264 (Direct) | View |
| 2023-12-21 Purchase | 2023-12-26 4:05 pm | Cyclacel Pharmaceuticals Inc. | CYCC | Rombotis Spiro George President and CEO | 6,070 | $3.315 | $20,122 | 74,728 (Direct) | View |
| 2021-11-30 Sale | 2021-12-02 4:07 pm | Cyclacel Pharmaceuticals Inc. | CYCC | BARKER SAM L Director | 12 | $3.5716 | $43 | 3,374 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-26 Option Award | 2025-02-28 4:48 pm | 2025-02-26 2035-02-26 | Cyclacel Pharmaceuticals Inc. | CYCC | NATAN DAVID Director | 700,000 | $0 | 700,000 (Direct) | View |
| 2025-02-26 Exercise | 2025-02-28 4:48 pm | N/A N/A | Cyclacel Pharmaceuticals Inc. | CYCC | Lazar David E. Interim CEO 10% Owner | 197,374,082 | $0 | 354,738 (Direct) | View |
| 2025-02-26 Option Award | 2025-02-28 4:47 pm | 2025-02-26 2035-02-26 | Cyclacel Pharmaceuticals Inc. | CYCC | Ben-Tzvi Avraham Director | 700,000 | $0 | 700,000 (Direct) | View |
Ownership | 2025-02-28 11:32 am | N/A N/A | Cyclacel Pharmaceuticals Inc. | CYCC | Doris Wong Sing Ee Chief Executive Officer 10% Owner | 0 | $0 | 194,628,820 (Direct) | View |
Ownership | 2025-02-28 11:31 am | N/A N/A | Cyclacel Pharmaceuticals Inc. | CYCC | Chong Kwang Fock Director | 0 | $0 | 0 (Direct) | View |
Ownership | 2025-02-28 11:31 am | N/A N/A | Cyclacel Pharmaceuticals Inc. | CYCC | Kiu Cu Seng CFO and Secretary | 0 | $0 | 0 (Direct) | View |
| 2025-02-06 Option Award | 2025-02-10 5:45 pm | 2025-02-06 N/A | Cyclacel Pharmaceuticals Inc. | CYCC | Lazar David E. Interim CEO 10% Owner | 2,100,000 | $0 | 3,100,000 (Direct) | View |
Ownership | 2025-01-08 5:25 pm | N/A N/A | Cyclacel Pharmaceuticals Inc. | CYCC | Ben-Tzvi Avraham Director | 0 | $0 | 0 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-07 7:07 pm | N/A N/A | Cyclacel Pharmaceuticals Inc. | CYCC | NATAN DAVID Director | 100,000 | $0 | 100,000 (Direct) | View |
Ownership | 2025-01-07 7:06 pm | N/A N/A | Cyclacel Pharmaceuticals Inc. | CYCC | NATAN DAVID Director | 0 | $0 | 0 (Direct) | View |
Ownership | 2025-01-07 7:04 pm | N/A N/A | Cyclacel Pharmaceuticals Inc. | CYCC | Lazar David E. Chief Executive Officer | 0 | $0 | 2,650,000 (Direct) | View |
| 2024-01-29 Option Award | 2024-01-31 4:56 pm | N/A 2034-01-29 | Cyclacel Pharmaceuticals Inc. | CYCC | SCHWARTZ BRIAN Interim Chief Medical Officer | 12,500 | $0 | 27,705 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-03 4:58 pm | 2024-06-30 2033-06-30 | Cyclacel Pharmaceuticals Inc. | CYCC | Rombotis Spiro George President and CEO | 110,000 | $0 | 110,000 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-03 4:57 pm | 2024-06-30 2033-06-30 | Cyclacel Pharmaceuticals Inc. | CYCC | BARKER SAM L Director | 63,657 | $0 | 82,853 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-03 4:57 pm | 2024-06-30 2033-06-30 | Cyclacel Pharmaceuticals Inc. | CYCC | Spiegel Robert J. Director | 63,657 | $0 | 81,853 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-03 4:57 pm | 2024-06-30 2033-06-30 | Cyclacel Pharmaceuticals Inc. | CYCC | McBarron Paul See Remarks | 70,200 | $0 | 70,200 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-03 4:56 pm | 2026-06-30 2033-06-30 | Cyclacel Pharmaceuticals Inc. | CYCC | Kirschbaum Mark Chief Medical Officer | 70,200 | $0 | 70,200 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-03 4:56 pm | 2024-06-30 2033-06-30 | Cyclacel Pharmaceuticals Inc. | CYCC | Walker Karin L Director | 63,657 | $0 | 83,040 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-03 4:56 pm | 2024-06-30 2033-06-30 | Cyclacel Pharmaceuticals Inc. | CYCC | Ferguson Kenneth M. Director | 63,657 | $0 | 87,390 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-03 4:55 pm | 2024-06-30 2033-06-30 | Cyclacel Pharmaceuticals Inc. | CYCC | HENNEY CHRISTOPHER S Director | 63,657 | $0 | 81,853 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-03 4:55 pm | 2024-06-30 2033-06-30 | Cyclacel Pharmaceuticals Inc. | CYCC | SCHWARTZ BRIAN Director | 63,657 | $0 | 83,040 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 4:19 pm | N/A N/A | Cyclacel Pharmaceuticals Inc. | CYCC | McBarron Paul See Remarks | 31,200 | $0 | 31,492 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 4:18 pm | N/A N/A | Cyclacel Pharmaceuticals Inc. | CYCC | Rombotis Spiro George President and CEO | 57,600 | $0 | 62,588 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 4:17 pm | N/A N/A | Cyclacel Pharmaceuticals Inc. | CYCC | Kirschbaum Mark Chief Medical Officer | 31,200 | $0 | 31,200 (Direct) | View |
| 2022-06-14 Option Award(A) | 2022-06-17 4:06 pm | 2023-06-14 2032-06-14 | Cyclacel Pharmaceuticals Inc. | CYCC | Ferguson Kenneth M. Director | 71,200 | $0 | 71,200 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 4:39 pm | 2023-06-14 2032-06-14 | Cyclacel Pharmaceuticals Inc. | CYCC | Ferguson Kenneth M. Director | 75,200 | $0 | 75,200 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 4:13 pm | 2023-06-14 2032-06-14 | Cyclacel Pharmaceuticals Inc. | CYCC | Walker Karin L Director | 47,467 | $0 | 51,028 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 4:12 pm | 2023-06-14 2032-06-14 | Cyclacel Pharmaceuticals Inc. | CYCC | Spiegel Robert J. Director | 47,467 | $0 | 49,841 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 4:11 pm | 2023-06-14 2032-06-14 | Cyclacel Pharmaceuticals Inc. | CYCC | Sems Lloyd Director | 47,467 | $0 | 49,841 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 4:11 pm | 2023-06-14 2032-06-14 | Cyclacel Pharmaceuticals Inc. | CYCC | SCHWARTZ BRIAN Director | 47,467 | $0 | 51,028 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 4:11 pm | 2023-06-14 2032-06-14 | Cyclacel Pharmaceuticals Inc. | CYCC | HENNEY CHRISTOPHER S Director | 47,467 | $0 | 49,841 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 4:10 pm | 2023-06-14 2032-06-14 | Cyclacel Pharmaceuticals Inc. | CYCC | BARKER SAM L Director | 47,467 | $0 | 50,841 (Direct) | View |
| 2021-12-13 Option Award(A) | 2021-12-16 4:16 pm | N/A 2031-12-13 | Cyclacel Pharmaceuticals Inc. | CYCC | Rombotis Spiro George President and CEO | 190,000 | $0 | 190,000 (Direct) | View |
| 2021-12-13 Option Award | 2021-12-15 4:20 pm | N/A 2031-12-13 | Cyclacel Pharmaceuticals Inc. | CYCC | Rombotis Spiro George President and CEO | 190,000 | $0 | 190,000 (Direct) | View |
| 2021-12-13 Option Award | 2021-12-15 4:19 pm | N/A 2031-12-13 | Cyclacel Pharmaceuticals Inc. | CYCC | McBarron Paul See Remarks | 100,000 | $0 | 100,000 (Direct) | View |
| 2021-12-13 Option Award | 2021-12-15 4:18 pm | N/A 2031-12-13 | Cyclacel Pharmaceuticals Inc. | CYCC | Kirschbaum Mark Chief Medical Officer | 100,000 | $0 | 100,000 (Direct) | View |